BNET Industries

Access Pharmaceuticals Inc.

(ACCP) is in the Pharma Industry

Market Cap:$24.5M
Last Fiscal Year Sales:$57.0K
  • Public
  • US
Dow Jones Description

Pharmaceuticals

CFO, Vice President & TreasurerStephen B. Thompson
Number of Employees 9
Contact Information

2600 Stemmons Freeway

Suite 176

Dallas, Texas 75207

www.accesspharm...

(214) 905-5100

NAICS Code Pharmaceutical Preparation Manufacturing: 325412

Recent Events

  • Access Pharmaceuticals Provides Update on Global Launch of MuGard

    5/27/09 - Product Announcement - View Story

  • Access Pharmaceuticals Provides Update on Global Launch of MuGardTM

    5/27/09 - Product Announcement - View Story

  • Access Pharmaceuticals Announces the European Launch of MuGardTM by its European...

    4/22/09 - Merger / Acquisition - View Story

  • Access Pharmaceuticals Announces Positive ProLindacTM Phase 2 Ovarian Cancer Clinical Trial Results

    3/05/09 - Licensing / Contract - View Story

  • Access Pharmaceuticals Closes Acquisition of MacroChem Corp.

    2/26/09 - Merger / Acquisition - View Story

  • Access Pharmaceuticals ACCP Licenses ProLindacTM and MuGardTM to JCOM Ltd

    2/19/09 - Joint Venture / Alliance - View Story

News & Analysis

Filter by

access pharmaceuticals inc. - All News and Analysis

Additional Resources

  • Valos Promotes From Within and Hires Fresh Talent

    - 2009-06-25

    Valos, a CommonHealth business unit createdto provide strategic marketing services to improve patient access topharmaceutical brands competing in managed markets, today announced onepromotion and six new hires. CommonHealth ( www.commonhealth.com ) is the world's leadinghealthcare-communications network and a WPP (NASDAQ: WPPGY) ( www.wpp.com )company. Promotion Suyen Segura has been promoted...

  • Access Pharmaceuticals Announces Initiation of Two New Cobalamin™ Oral Insulin Drug Delivery Collaborations

    - 2009-06-17

    Cobalamin oral insulin and oral human growth hormone formulations provide significant pharmacological responses DALLAS, June 17 /PRNewswire-FirstCall/ -- ACCESS PHARMACEUTICALS, INC. (BULLETIN BOARD: ACCP) announced today that the Company has signed evaluation agreements with two biopharmaceutical companies for its CobalaminTM Oral Drug Delivery Technology. Under...

  • Access Pharmaceuticals Announces Granting of Two US Patents for MuGard™

    - 2009-06-10

    Commercial Launch of MuGard in Europe Ongoing DALLAS, June 10 /PRNewswire-FirstCall/ -- ACCESS PHARMACEUTICALS, INC. (BULLETIN BOARD: ACCP) , announced today that the Company has received issue notifications from the United States Patent and Trademark Office that two US patents relating to MuGardTM, the Company's approved...

  • Chandler Chicco Companies Announces New Brandtectonics Access US Offering

    - 2009-06-05

    NEW YORK, June 5 /PRNewswire/ -- Chandler Chicco Companies CCC, an inVentiv Health global healthcare communications network, today announced the US launch of Brandtectonics Access, a specialist market access consultancy that designs, facilitates and delivers unique, tailored solutions to optimize patient access to pharmaceutical brands. The US arm...

Decision Makers

Name (plus bio) Position
Stephen B. Thompson CFO, Vice President & Treasurer
David P. Nowotnik Senior Vice President, Res
Daniel G. Moro Vice President
Gregory J. Russell-Jones Vice President
Maurie Markman Vice President, Res
Phillip Wise Vice President, Business Development & Strategy
Rhone-Poulenc Rorer Vice President
J. Michael Flinn Director
Robert Woolley Controller

Board of Directors

Name (plus bio) Position
Herbert H. McCade Board of Directors
Herbert H. McDade Board of Directors
J. Michael Finn Board of Directors
Jeffrey B. Davis Board of Directors
John J. Meakem Board of Directors
Mark J. Ahn Board of Directors
Mark J. Alvino Board of Directors
Max Link Board of Directors
Stephen B. Howell Board of Directors
Stuart M. Duty Board of Directors
Organization Position Status
Access Pharmaceuticals, Inc. CFO, Vice President & Treasurer Current
Access Pharmaceuticals, Inc. Vice President, CFO Current
Santa Fe International Corporation Former
Organization Position Status
Access Pharmaceuticals, Inc. Senior Vice President, Res Current
Organization Position Status
Access Pharmaceuticals, Inc. Vice President Current
Organization Position Status
Access Pharmaceuticals, Inc. Vice President Current
Organization Position Status
Access Pharmaceuticals, Inc. Vice President, Res Current
Organization Position Status
Access Pharmaceuticals, Inc. Vice President, Business Development & Strategy Current
Organization Position Status
Access Pharmaceuticals, Inc. Vice President Current
Organization Position Status
Access Pharmaceuticals, Inc. Director Current
Access Pharmaceuticals, Inc. Board of Directors Current
Organization Position Status
Access Pharmaceuticals, Inc. Controller Current
Organization Position Status
Access Pharmaceuticals, Inc. Board of Directors Current
Organization Position Status
Lehman Brothers Holdings Inc. President & Chief Operating Officer Current
Access Pharmaceuticals, Inc. Board of Directors Current
Discovery Laboratories, Inc. Board of Directors Current
Lehman Brothers Holdings Inc. Global Head, Equities Former
Lehman Brothers Holdings Inc. Global Head, Fixed Income Division Former
University of Michigan M.B.A. Former
Duke University B.A. Former
Organization Position Status
Access Pharmaceuticals, Inc. Board of Directors Current
Organization Position Status
Access Pharmaceuticals, Inc. Board of Directors Current
Organization Position Status
Access Pharmaceuticals, Inc. Board of Directors Current
Organization Position Status
Access Pharmaceuticals, Inc. Board of Directors Current
Organization Position Status
Access Pharmaceuticals, Inc. Board of Directors Current
Organization Position Status
Access Pharmaceuticals, Inc. Board of Directors Current
Organization Position Status
Access Pharmaceuticals, Inc. Board of Directors Current

Executive News

  • Access Pharmaceuticals Announces Initiation of Two New Cobalamin Oral Insulin Drug Delivery Collaborations

    Pharma Live - 6/20/09 - View Story

  • Access Pharmaceuticals (ACCP) Announces Initiation of Two New Cobalamin(TM) Oral Insulin Drug Delivery Collaborations

    BioSpace - 6/18/09 - View Story

  • Access Pharmaceuticals Announces Initiation of Two New Cobalamin(TM) Oral Insulin...

    Reuters - 6/17/09 - View Story

  • Access Pharmaceuticals Announces Initiation of Two New Cobalamin(TM) Oral Insulin Drug Delivery Collaborations

    PR Newswire - 6/17/09 - View Story

  • Access Pharmaceuticals: Gaining Momentum

    Seeking Alpha - 6/11/09 - View Story

  • Access Pharmaceuticals Announces Granting of Two US Patents for MuGard(TM)

    PR Newswire - 6/10/09 - View Story

  • Access Pharmaceuticals Announces Publication of Thiarabine Combination Data

    Pharma Live - 6/05/09 - View Story

  • Access Pharmaceuticals Announces Publication of Thiarabine Combination Data

    PR Newswire - 6/04/09 - View Story

  • Access Pharmaceuticals Announces Publication of Thiarabine Combination Data

    PR Newswire - 6/04/09 - View Story

  • Access Pharmaceuticals (ACCP) Provides Update on ProLindac(TM) Phase 2 Ovarian Cancer Trial and Clinical Development Plan

    BioSpace - 6/01/09 - View Story

  • Access Pharmaceuticals Provides Update on ProLindac(TM) Phase 2 Ovarian Cancer Trial and Clinical Development Plan

    PR Newswire - 6/01/09 - View Story

  • Access Pharmaceuticals Provides Update on Global Launch of MuGard

    Pharma Live - 5/27/09 - View Story

  • Access Pharmaceuticals Provides Update on Global Launch of MuGard(TM)

    Reuters - 5/27/09 - View Story

  • Access Pharmaceuticals Provides Update on Global Launch of MuGard(TM)

    San Francisco Business Times - 5/27/09 - View Story

  • Access Pharmaceuticals Provides Update on Global Launch of MuGard(TM)

    Street Insider - 5/27/09 - View Story

advertisement
     ACCP $2.20 -0.05 (-2.22% )
Intraday | 3 Month | 6 Month | 1 Year
Average Volume 21,016
Shares Outstanding 11.32M
Market Cap 24.9M
Year High 3.5
Year Low 0.75
Earnings Per Share N/A
P/E Ratio -
Dividend N/A
Yield N/A
Glass Door

Pharma Industry Companies

Company Employer Rating
Pfizer 3.0
IndustryTop Rated

Brought to you by CBS MoneyWatch.com

advertisement